Akari Therapeutics Plc (AKTX) stock
AKTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.70−0.81 (-12.44%)
Close on Nov 17, 2026Market cap $11.10MP/E –Yield –
Akari Therapeutics cash
Cash and short-term investments held at the end of each period.
Akari Therapeutics's cash was $7.69M at Jun 30, 2026. For fiscal 2025 it was $5.20M, up 95.7% from the year before. Over ten years it grew -22.8% a year on average. The highest annual figure on record is $69.06M in fiscal 2015.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.20M | +95.7% |
| FY2024 | Dec 31, 2024 | $2.66M | -30.8% |
| FY2023 | Dec 31, 2023 | $3.85M | -71.0% |
| FY2022 | Dec 31, 2022 | $13.25M | +41.5% |
| FY2021 | Dec 31, 2021 | $9.36M | -33.4% |
| FY2020 | Dec 31, 2020 | $14.06M | +145.2% |
| FY2019 | Dec 31, 2019 | $5.73M | -4.0% |
| FY2018 | Dec 31, 2018 | $5.97M | -78.9% |
| FY2017 | Dec 31, 2017 | $28.25M | -36.2% |
| FY2016 | Dec 31, 2016 | $44.26M | -35.9% |
| FY2015 | Dec 31, 2015 | $69.06M | +1975.5% |
| FY2014 | Dec 31, 2014 | $3.33M | +501.0% |
| FY2013 | Dec 31, 2013 | $553.65K | -49.9% |
| FY2012 | Dec 31, 2012 | $1.10M | +18300.0% |
| FY2011 | Dec 31, 2011 | $6.00K | -33.3% |
| FY2010 | Dec 31, 2010 | $9.00K | +200.0% |
| FY2009 | Dec 31, 2009 | $3.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $7.69M | +183.8% |
| Q1 FY2026 | Mar 31, 2026 | $2.77M | +7.2% |
| Q4 FY2025 | Dec 31, 2025 | $5.20M | +95.7% |
| Q3 FY2025 | Sep 30, 2025 | $2.48M | +10.6% |
| Q2 FY2025 | Jun 30, 2025 | $2.71M | -35.1% |
| Q1 FY2025 | Mar 31, 2025 | $2.58M | +97.1% |
| Q4 FY2024 | Dec 31, 2024 | $2.66M | -30.8% |
| Q3 FY2024 | Sep 30, 2024 | $2.25M | -52.5% |
| Q2 FY2024 | Jun 30, 2024 | $4.18M | -41.8% |
| Q1 FY2024 | Mar 31, 2024 | $1.31M | -88.7% |
| Q4 FY2023 | Dec 31, 2023 | $3.85M | -71.0% |
| Q3 FY2023 | Sep 30, 2023 | $4.73M | -42.0% |
| Q2 FY2023 | Jun 30, 2023 | $7.18M | -23.3% |
| Q1 FY2023 | Mar 31, 2023 | $11.58M | +205.5% |
| Q4 FY2022 | Dec 31, 2022 | $13.25M | -5.7% |
| Q2 FY2022 | Jun 30, 2022 | $8.15M | -33.8% |
| Q4 FY2021 | Dec 31, 2021 | $9.36M | -26.6% |
| Q2 FY2021 | Jun 30, 2021 | $3.79M | -51.5% |
| Q4 FY2020 | Dec 31, 2020 | $14.06M | +145.2% |
| Q3 FY2020 | Sep 30, 2020 | $12.32M | +96.5% |
| Q2 FY2020 | Jun 30, 2020 | $12.75M | +365.8% |
| Q1 FY2020 | Mar 31, 2020 | $7.82M | +27.3% |
| Q4 FY2019 | Dec 31, 2019 | $5.73M | -4.0% |
| Q3 FY2019 | Sep 30, 2019 | $6.27M | -59.8% |
| Q2 FY2019 | Jun 30, 2019 | $2.74M | -90.3% |
| Q1 FY2019 | Mar 31, 2019 | $6.15M | -79.6% |
| Q4 FY2018 | Dec 31, 2018 | $5.97M | -86.5% |
| Q2 FY2018 | Jun 30, 2018 | $15.59M | -72.0% |
| Q4 FY2017 | Dec 31, 2017 | $28.25M | -54.0% |
| Q2 FY2017 | Jun 30, 2017 | $30.12M | -56.4% |
| Q4 FY2016 | Dec 31, 2016 | $44.26M | -43.8% |
| Q2 FY2016 | Jun 30, 2016 | $55.78M | +27591.4% |
| Q1 FY2016 | Mar 31, 2016 | $61.43M | +4523.4% |
| Q4 FY2015 | Dec 31, 2015 | $69.06M | +1975.5% |
| Q3 FY2015 | Sep 30, 2015 | $78.77M | +149618.5% |
| Q2 FY2015 | Jun 30, 2015 | $201.44K | -98.2% |
| Q1 FY2015 | Mar 31, 2015 | $1.33M | – |
| Q4 FY2014 | Dec 31, 2014 | $3.33M | – |
| Q3 FY2014 | Sep 30, 2014 | $52.61K | – |
| Q2 FY2014 | Jun 30, 2014 | $11.36M | – |
See a number that looks wrong?